Protein tyrosine phosphatase 1B (PTP1B) is a key negative regulator of insulin and leptin signaling, which suggests that it is an attractive therapeutic target in type II diabetes and obesity. Here, LEP is linked to obesity due to melanocortin 4 receptor deficiency.